Skip to main content
HIKMA Pharmaceuticals PLC logo

HIKMA Pharmaceuticals PLC — Investor Relations & Filings

Ticker · HIK ISIN · GB00B0LCW083 LEI · 549300BNS685UXH4JI75 IL Manufacturing
Open in API
Filings indexed 827 across all filing types
Latest filing 2026-04-13 Director's Dealing
Country GB United Kingdom
Listing IL HIK

About HIKMA Pharmaceuticals PLC

https://www.hikma.com/home/

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 98% confidence The document is a Regulatory News Service (RNS) announcement disclosing transactions by Persons Discharging Managerial Responsibilities (PDMRs) – share vesting and sales by executives under the LTIP. This matches the definition of Director’s Dealing (insider share transactions).
2026-04-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is a disclosure under Article 5(1)(b) of Regulation (EU) No 596/2014 by Hikma Pharmaceuticals PLC detailing the number of ordinary shares repurchased under its $250 million buyback programme, including aggregate volumes, prices and individual trade schedule. This matches the definition of a company transaction in its own shares (share repurchase) rather than an earnings release or board change. Therefore, it is classified as a Transaction in Own Shares.
2026-04-13 English
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS announcement under EU Market Abuse Regulation Article 19 disclosing share awards (insider transactions) to PDMRs and executives. It details the nature, volume, and date of awards granted to directors and senior management, matching the definition of a Director’s Dealing report.
2026-04-09 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a short RNS announcement under FCA DTR 5.6.1 notifying the market of the company’s total voting rights and issued share capital as at a specific date. It is not a shareholder notification or share issue, nor an earnings or financial report, but a Voting Rights Announcement. This matches the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-04-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 93% confidence The document is an RNS announcement titled "Transaction in Own Shares" detailing the number, dates, prices, venues and total of ordinary shares repurchased under a share buyback programme. It provides a full schedule of individual trades during the disclosure period, which is exactly the content of a share repurchase/issuance report. This corresponds to category #29: Transaction in Own Shares (POS).
2026-03-30 English
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is an RNS announcement titled “Transaction in Own Shares” by Hikma Pharmaceuticals, describing the company’s share repurchase programme, detailing aggregate repurchases and individual trades. This clearly matches the category for company buyback or sale of its own shares.
2026-03-23 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.